[3H]Acetylcholine release from rat amacrine-like neurons is inhibited by adenosine A1 receptor activation

NeuroReport

Volumn 9, Issue 16, 1998, Pages 3693-3698

  Santos, Paulo F ^a   Caramelo, Olga L ^a   Carvalho, Arsélio P ^a   Duarte, Carlos B ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Acetylcholine release; Adenosine A1 receptors; Amacrine cells; Rat; Retina

Indexed keywords

4 AMINOBUTYRIC ACID; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ACETYLCHOLINE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE DEAMINASE; CALCIUM 45; CHOLINE ACETYLTRANSFERASE; POTASSIUM CHLORIDE; 1,3-DIPROPYL-8-CYCLOPENTYLXANTHINE; ADENOSINE RECEPTOR; CALCIUM; CALCIUM CHANNEL; DIAGNOSTIC AGENT; TRITIUM; XANTHINE DERIVATIVE;

ACETYLCHOLINE RELEASE; ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CELL MEMBRANE DEPOLARIZATION; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA AMACRINE CELL; ANIMAL; CELL CULTURE; CELL MEMBRANE POTENTIAL; CHANNEL GATING; CHEMISTRY; CYTOLOGY; DRUG EFFECT; ELECTROSTIMULATION; ENZYMOLOGY; METABOLISM; NEWBORN; PHYSIOLOGY; RETINA; WISTAR RAT;

ACETYLCHOLINE; ADENOSINE DEAMINASE; ANIMALS; ANIMALS, NEWBORN; CALCIUM CHANNELS; CALCIUM RADIOISOTOPES; CELLS, CULTURED; CHOLINE O-ACETYLTRANSFERASE; ELECTRIC STIMULATION; GAMMA-AMINOBUTYRIC ACID; ION CHANNEL GATING; MEMBRANE POTENTIALS; POTASSIUM CHLORIDE; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P1; RETINA; TRITIUM; XANTHINES;

EID: 0032538658     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199811160-00023     Document Type: Article

References (24)

1. Wässle H and Boycott BB. Physiol Rev 71, 447-480 (1991).
2. Iuvone PM. Neurotransmitters and neuromodulators in the retina: regulation, interactions and cellular effects. In: Adler R and Faber D, eds. The Retina: A Model for Cell Biology Studies, Part II. Orlando: Academic Press, 1986: 1-72.
3. Voigt T. J Comp Neurol 248, 19-35 (1986).
4. Larsen AK and Osborne NN. Invest Ophthalmol Vis Sci 37, 2603-2611 (1996).
5. Fredholm BB and Dunwiddie TV. Trends Pharmacol Sci 9, 130-134 (1988).
6. Scholz KP and Miller RJ. J Physiol 435, 373-393 (1991).
7. Yawo H and Chuhma N. Nature 365, 256-258 (1993).
8. Gerber U, Greene RW, Haas HL et al. J Physiol 417, 567-578 (1989).
9. Blazynski C and Perez MTR. Cell Mol Neurobiol 11, 463-484 (1991).
10. Blazynski C, Wood C and Mathews GC. J Neurochem 58, 761-767 (1992).
11. Carvalho AL, Duarte CB, Faro CJ et al. J Neurochem 70, 2112-2119 (1998).
12. Duarte CB, Ferreira IL, Santos PF et al. Brain Res 591, 27-32 (1992).
13. Rand JB and Johnson CD. Anal Biochem 116, 361-371 (1981).
14. Jann R and Sudhof TC. Annu Rev Neurosci 17, 219-246 (1994).
15. Yawo H, Chuhma N and Endo K. Biomed Res 15, 9-16 (1994).
16. Strettoi E and Masland RH. Proc Natl Acad Sci USA 93, 14906-14911 (1996).
17. Tamura N, Yokotani K, Okuma Y et al. Brain Res 676, 363-370 (1995).
18. Paes de Carvalho R, Braas KM, Snyder SH et al. J Neurochem 55, 1603-1611 (1990).
19. Perez MTR, Ehinger BE, Linstrom K et al. Brain Res 398 (1986).
20. Liu SXL and Chiou GCY. J Ocul Pharmacol Ther 12, 377-386 (1996).
21. Neal MJ, Cunningham JR, Hutson PH et al. J Neurochem 627, 1025-1033 (1994).
22. Rego AC, Santos MS and Oliveira CR. J Neurochem 69, 1228-1235 (1997).
23. Roth S, Osinski JV, Park SS et al. J Neurosci Methods 68, 87-90 (1996).
24. Roth S, Park SS, Sikorski CW et al. Curr Eye Res 16, 875-885 (1997).